Hoffmann La Roche Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOFFMANN LA ROCHE, and when can generic versions of HOFFMANN LA ROCHE drugs launch?
HOFFMANN LA ROCHE has ten approved drugs.
There are six US patents protecting HOFFMANN LA ROCHE drugs.
There are one hundred and eighty patent family members on HOFFMANN LA ROCHE drugs in forty-six countries and twenty-three supplementary protection certificates in seventeen countries.
Summary for Hoffmann La Roche
International Patents: | 180 |
US Patents: | 6 |
Tradenames: | 9 |
Ingredients: | 8 |
NDAs: | 10 |
Drugs and US Patents for Hoffmann La Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 8,741,920 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 8,470,818 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hoffmann La Roche | ROCEPHIN KIT | ceftriaxone sodium; lidocaine | INJECTABLE;INJECTION | 050585-006 | May 8, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INJECTION | 063239-003 | Aug 13, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hoffmann La Roche | ROCEPHIN KIT | ceftriaxone sodium; lidocaine | INJECTABLE;INJECTION | 050585-007 | May 8, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hoffmann La Roche | ROCEPHIN | ceftriaxone sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 050585-004 | Dec 21, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hoffmann La Roche
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann La Roche | BONIVA | ibandronate sodium | TABLET;ORAL | 021455-002 | Mar 24, 2005 | 7,718,634 | ⤷ Try a Trial |
Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-003 | May 7, 1982 | 4,322,438 | ⤷ Try a Trial |
Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-004 | Mar 28, 1983 | 4,464,394*PED | ⤷ Try a Trial |
Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-002 | May 7, 1982 | 4,464,394*PED | ⤷ Try a Trial |
Hoffmann La Roche | ROMAZICON | flumazenil | INJECTABLE;INJECTION | 020073-001 | Dec 20, 1991 | 4,316,839 | ⤷ Try a Trial |
Hoffmann La Roche | ACCUTANE | isotretinoin | CAPSULE;ORAL | 018662-004 | Mar 28, 1983 | 4,200,647 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HOFFMANN LA ROCHE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 2.5 mg and 150 mg | ➤ Subscribe | 2007-05-16 |
➤ Subscribe | Injection | 1 mg/mL, 3 mL Vial | ➤ Subscribe | 2007-08-31 |
International Patents for Hoffmann La Roche Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 102574799 | ⤷ Try a Trial |
European Patent Office | 1885723 | ⤷ Try a Trial |
Ukraine | 95244 | ⤷ Try a Trial |
Israel | 214328 | ⤷ Try a Trial |
New Zealand | 565255 | ⤷ Try a Trial |
Hong Kong | 1168590 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hoffmann La Roche Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1893612 | 2012/025 | Ireland | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/12/751/001 20120217 |
1893612 | 12C0040 | France | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB, EVENTUELLEMENT SOUS LA FORME D'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/12/751/001 20120221 |
1893612 | 1290026-2 | Sweden | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB OCH FARMACEUTISKT GODTAGBARA SALTER DAERAV; REG. NO/DATE: EU/1/12/751/001 20120217 |
1893612 | 28/2012 | Austria | ⤷ Try a Trial | PRODUCT NAME: VEMURAFENIB UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; REGISTRATION NO/DATE: EU/1/12/751/001 (MITTEILUNG) 20120221 |
0034432 | 96C0048 | Belgium | ⤷ Try a Trial | PRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004 |
1893612 | 122 5012-2012 | Slovakia | ⤷ Try a Trial | FIRST REGISTRATION NO/DATE: EU/1/12/751/001, 20120217 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.